Citrobacter freundii high in stool: what the finding supports

Published October 7, 2026 · Updated November 18, 2026 · 5 min read

A high Citrobacter freundii result on a GI-MAP test means the measured stool DNA quantity exceeds the laboratory’s reference value. It does not, by itself, show that this organism is causing your symptoms or that you need an antibiotic. Read the species result alongside the specimen type, symptoms and any separate clinical tests.

On this page

Species, genus and colonization

C. freundii is one species within the Citrobacter genus. Researchers have recovered it and other Enterobacterales from healthy people’s intestinal microbiota. Finding an organism can reflect carriage, also called colonization; it is not automatically evidence of an infection. A species name also does not reveal the organism’s complete strain or resistance profile. [1]

The GI-MAP sample report lists Citrobacter spp. and C. freundii separately. This guide addresses the species line. Use the genus guide when your question concerns the broader group. Neither line establishes that Citrobacter caused an autoimmune condition; the report’s category is not a clinical diagnosis.

Reading the GI-MAP number

The manufacturer’s sample report shows a C. freundii result of <dl, meaning below the detectable limit, beside a reference of <5.00e5. These are different columns: the reference is not that sample’s measured result. [2]

  • 5.00e5 means 500,000. The report describes its microbial quantities as genome equivalents per gram of stool, based on DNA analysis. This is not a culture count of living organisms.
  • Illustrative high result: a value of 1.00e6 beside a reference of <5.00e5 would be above that reference. It would not mean symptoms are twice as severe, or establish an infection.
  • Use your own report: check its units, reference column and collection date. Do not substitute the genus reference of <5.00e6 for the species reference.

For help with scientific notation and other report sections, see the GI-MAP sample-report walkthrough. A value within range or below detection also cannot rule out every cause of ongoing symptoms.

Antibiotic resistance: what this result cannot tell you

There is a real species-specific reason clinicians pay attention to C. freundii: current IDSA guidance identifies it among organisms with a moderate risk of clinically significant inducible AmpC production. AmpC is an enzyme that can affect susceptibility to certain antibiotics. That guidance concerns treating infections, with attention to the organism and clinical circumstances. It is not a recommendation to treat every stool finding. [3]

A high GI-MAP quantity is not an antibiotic-susceptibility result and does not establish an ESBL-producing or carbapenem-resistant infection. If a separate urine, blood or other clinical culture identifies C. freundii, bring the specimen source, date and susceptibility report to the treating clinician. The stool number cannot choose a drug, prove the same strain is present elsewhere, or confirm that treatment has cleared an infection.

Symptoms and next steps

Persistent diarrhea, unexplained weight loss or significant pain deserves clinical assessment. Review the overall problem rather than assuming one flagged species explains it. If you are immunocompromised and develop fever or feel acutely unwell, contact your care team promptly.

Seek urgent medical help for possible serious infection, particularly with new confusion, shortness of breath or extreme pain. Do not wait for a stool retest. Sepsis requires medical assessment; a GI-MAP number cannot assess or exclude it. [4]

Common questions

Is a high C. freundii result proof of a resistant infection?

No. The quantity alone establishes neither active infection nor which antibiotics would work. Clinicians distinguish colonization from infection and use relevant clinical and laboratory evidence before deciding on treatment.

Should the genus and species counts match?

Read each target against its own reference. The genus includes more than this one species, and the report presents separate measurements. Do not add the two lines together or treat their difference as a diagnosis. Ask the laboratory about unexpected patterns.

Does a negative stool result exclude a C. freundii urinary infection?

No. Stool and urine are different specimens. Urinary symptoms and a urine test need their own clinical interpretation, even when the stool result is below detection.

Sources and review

Sources checked November 18, 2026. Manufacturer material explains report formatting and measurement; primary research and clinical guidance inform the interpretation limits.

  1. Primary study: non-E. coli Enterobacterales from healthy subjects’ gut microbiota (2020)
  2. Diagnostic Solutions Laboratory: GI-MAP sample report (2025), pages 1 and 3
  3. IDSA 2026 antimicrobial-resistant Gram-negative infection guidance: general management and AmpC section
  4. CDC: About Sepsis (updated August 2026)

This article has been reviewed by Madison Ordway, FDN-P. For a correction or source question, contact Gi Map Test.